A malaria vaccine based on the polymorphic block 2 region of MSP-1 that elicits a broad serotype-spanning immune response

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Cowan, Graeme J M ^a   Creasey, Alison M ^a   Dhansarnsombut, Kelwalin ^a   Thomas, Alan W ^b   Remarque, Edmond J ^b   Cavanagh, David R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COVACCINE HT; EPITOPE; HYBRID PROTEIN; IMMUNOLOGICAL ADJUVANT; MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 1; UNCLASSIFIED DRUG; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; PROTOZOON ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ANTIGEN PRESENTATION; ANTIGEN PURIFICATION; ARTICLE; CHILD; CONTROLLED STUDY; DRUG FORMULATION; ENDEMIC DISEASE; FED BATCH FERMENTATION; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALARIA; MOUSE; NONHUMAN; SEROTYPE; THERMOSTABILITY; ADOLESCENT; ADULT; ANIMAL; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DBA MOUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GROWTH, DEVELOPMENT AND AGING; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOLOGY; MACACA MULATTA; MALARIA FALCIPARUM; MASS SPECTROMETRY; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; RABBIT;

ANIMALIA; PLASMODIUM FALCIPARUM;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, PROTOZOAN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOGLOBULIN G; MACACA MULATTA; MALARIA VACCINES; MALARIA, FALCIPARUM; MEROZOITE SURFACE PROTEIN 1; MICE; MICE, INBRED DBA; PLASMODIUM FALCIPARUM; RABBITS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 80055045168     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026616     Document Type: Article

References (64)

1. Osier FH, Fegan G, Polley SD, Murungi L, Verra F, et al. (2008) Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infection and Immunity 76: 2240-2248.
2. Metzger WG, Okenu DM, Cavanagh DR, Robinson JV, Bojang KA, et al. (2003) Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria. Parasite Immunology 25: 307-312.
3. Conway DJ, Cavanagh DR, Tanabe K, Roper C, Mikes ZS, et al. (2000) A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nature Medicine 6: 689-692.
4. Stanisic DI, Richards JS, McCallum FJ, Michon P, King CL, et al. (2009) Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Infection and Immunity 77: 1165-1174.
5. Polley SD, Mwangi T, Kocken CHM, Thomas AW, Dutta S, et al. (2004) Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. Vaccine 23: 718.
6. Conway DJ, Cavanagh DR, Tanabe K, Roper C, Mikes ZS, et al. (2000) A principal target of immunity to malaria identified by molecular population genetic and immunological analysis. Nature Medicine 6: 689.
7. Polley SD, Tetteh KK, Cavanagh DR, Pearce RJ, Lloyd JM, et al. (2003) Repeat sequences in block 2 of Plasmodium falciparum merozoite surface protein 1 are targets of antibodies associated with protection from malaria. Infect Immun 71: 1833.
8. Conway DJ, (1997) Natural selection on polymorphic malaria antigens and the search for a vaccine. Parasitology Today 13: 26.
9. Cohen S, McGregor IA, Carrington S, (1961) Gamma-globulin and acquired immunity to human malaria. Nature pp. 733.
10. Weiss GE, Traore B, Kayentao K, Ongoiba A, Doumbo S, et al. (2010) The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections. PLoS Pathog 6: e1000912.
11. Osier FH, Fegan G, Polley SD, Murungi L, Verra F, et al. (2008) Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun 76: 2240-2248.
12. Le Roch KG, Zhou Y, Blair PL, Grainger M, Moch JK, et al. (2003) Discovery of gene function by expression profiling of the malaria parasite life cycle. Science 301: 1503-1508.
13. Sanders PR, Cantin GT, Greenbaum DC, Gilson PR, Nebl T, et al. (2007) Identification of protein complexes in detergent-resistant membranes of Plasmodium falciparum schizonts. Mol Biochem Parasitol 154: 148-157.
14. Sanders PR, Gilson PR, Cantin GT, Greenbaum DC, Nebl T, et al. (2005) Distinct protein classes including novel merozoite surface antigens in Raft-like membranes of Plasmodium falciparum. J Biol Chem 280: 40169-40176.
15. McBride JS, Heidrich HG, (1987) Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex. Molecular and Biochemical Parasitology 23: 71-84.
16. Blackman MJ, Heidrich HG, Donachie S, McBride JS, Holder AA, (1990) A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J Exp Med 172: 379-382.
17. Cavanagh DR, McBride JS, (1997) Antigenicity of recombinant proteins derived from Plasmodium falciparum merozoite surface protein 1. Mol Biochem Parasitol 85: 197-211.
18. McBride JS, Heidrich HG, (1987) Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex. Mol Biochem Parasitol 23: 71-84.
19. Szarfman A, Walliker D, McBride JS, Lyon JA, Quakyi IA, et al. (1988) Allelic forms of gp195, a major blood-stage antigen of Plasmodium falciparum, are expressed in liver stages. Journal of Experimental Medicine 167: 231.
20. Krzych U, Lyon JA, Jareed T, Schneider I, Hollingdale MR, et al. (1995) T-lymphocytes from volunteers immunised with irradiated Plasmodium falciparum sporozoites recognise liver and blood-stage malaria antigens. Journal of Immunology 155: 4072.
21. Jiang GF, Daubenberger C, Huber W, Matile H, Tanner M, et al. (2000) Sequence diversity of the merozoite surface protein 1 of Plasmodium falciparum in clinical isolates from the Kilombero District, Tanzania. Acta Tropica 74: 51.
22. Miller LH, Roberts T, Shahabuddin M, McCutchan TF, (1993) Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Molecular & Biochemical Parasitology 59: 1.
23. Cavanagh DR, Dodoo D, Hviid L, Kurtzhals JA, Theander TG, et al. (2004) Antibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria. Infection and Immunity 72: 6492-6502.
24. Mawili-Mboumba DP, Borrmann S, Cavanagh DR, McBride JS, Matsiegui PB, et al. (2003) Antibody Responses to Plasmodium falciparum Merozoite Surface Protein-1 and Efficacy of Amodiaquine in Gabonese Children with P. falciparum Malaria. JInfectDis 187: 1137.
25. Cavanagh DR, Dodoo D, Hviid L, Kurtzhals JA, Theander TG, et al. (2004) Antibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria. Infect Immun 72: 6492.
26. Dodoo D, Theander TG, Kurtzhals JA, Koram K, Riley E, et al. (1999) Levels of antibody to conserved parts of Plasmodium falciparum merozoite surface protein 1 in Ghanaian children are not associated with protection from clinical malaria. Infection & Immunity 67: 2131.
27. Tebo AE, Kremsner PG, Luty AJ, (2001) Plasmodium falciparum: a major role for IgG3 in antibody-dependent monocyte-mediated cellular inhibition of parasite growth in vitro. Exp Parasitol 98: 20-28.
28. Cavanagh DR, Dobano C, Elhassan IM, Marsh K, Elhassan A, et al. (2001) Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum. Infect Immun 69: 1207-1211.
29. Tebo AE, Kremsner PG, Luty AJF, (2001) Plasmodium falciparum: A major role for IgG3 in antibody- dependent monocyte-mediated cellular inhibition of parasite growth in vitro. Experimental Parasitology 98: 20.
30. Galamo CD, Jafarshad A, Blanc C, Druilhe P, (2009) Anti-MSP1 Block 2 Antibodies Are Effective at Parasite Killing in an Allele-Specific Manner by Monocyte-Mediated Antibody-Dependent Cellular Inhibition. The Journal of Infectious Diseases 199: 1151-1154.
31. Sarthou JL, Angel G, Aribot G, Rogier C, Dieye A, et al. (1997) Prognostic value of anti-Plasmodium falciparum-specific immunoglobulin G3, cytokines, and their soluble receptors in West African patients with severe malaria. Infect Immun 65: 3271-3276.
32. Stubbs J, Olugbile S, Saidou B, Simpore J, Corradin G, et al. (2011) Strain-transcending Fc-dependent killing of Plasmodium falciparum by merozoite surface protein 2 allele-specific human antibodies. Infection and Immunity 79: 1143-1152.
33. Cavanagh DR, McBride JS, (1997) Antigenicity of recombinant proteins derived from Plasmodium falciparum merozoite surface protein 1. Molecular & Biochemical Parasitology 85.
34. Quakyi IA, Currier J, Fell A, Taylor DW, Roberts T, et al. (1994) Analysis of human T cell clones specific for conserved peptide sequences within malaria proteins. Paucity of clones responsive to intact parasites. JImmunol 153: 2082.
35. Parra M, Hui G, Johnson AH, Berzofsky JA, Roberts T, et al. (2000) Characterization of conserved T- and B-cell epitopes in Plasmodium falciparum major merozoite surface protein 1. Infection And Immunity 68: 2685.
36. Bowater RP, Wells RD, (2001) The intrinsically unstable life of DNA triplet repeats associated with human hereditary disorders. Progress in Nucleic Acid Research and Molecular Biology 66: 159-202.
37. Tetteh KK, Cavanagh DR, Corran P, Musonda R, McBride JS, et al. (2005) Extensive antigenic polymorphism within the repeat sequence of the Plasmodium falciparum merozoite surface protein 1 block 2 is incorporated in a minimal polyvalent immunogen. Infect Immun 73: 5928-5935.
38. Paganotti GM, Palladino C, Modiano D, Sirima BS, Raberg L, et al. (2006) Genetic complexity and gametocyte production of Plasmodium falciparum in Fulani and Mossi communities in Burkina Faso. Parasitology 132: 607-614.
39. Tompa P, (2003) Intrinsically unstructured proteins evolve by repeat expansion. Bioessays 25: 847.
40. Tompa P, (2002) Intrinsically unstructured proteins. Trends Biochem Sci 27: 527-533.
41. Cavanagh DR, McBride JS, (1997) Antigenicity of recombinant proteins derived from Plasmodium falciparum merozoite surface protein 1. Molecular and Biochemical Parasitology 85: 197-211.
42. Oeuvray C, Bouharoun-Tayoun H, Gras-Masse H, Bottius E, Kaidoh T, et al. (1994) Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes. Blood 84: 1594.
43. Soe S, Theisen M, Roussilhon C, Khin SA, Druilhe P, (2004) Association between protection, against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendernicity in myanmar: Complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein. Infection And Immunity 72: 247.
44. Ramasamy, Yasawardena, Kanagaratnam, Buratti, Baralle, et al. (1999) Antibodies to a merozoite surface protein promote multiple invasion of red blood cells by malaria parasites. Parasite Immunology 21: 397.
45. Ogutu BR, Apollo OJ, McKinney D, Okoth W, Siangla J, et al. (2009) Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya. PLoS ONE 4: e4708.
46. Fluck C, Smith T, Beck HP, Irion A, Betuela I, et al. (2004) Strain-specific humoral response to a polymorphic malaria vaccine. Infection and Immunity 72: 6300-6305.
47. Genton B, Betuela I, Felger I, Al-Yaman F, Anders RF, et al. (2002) A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. Journal of Infectious Diseases 185: 820-827.
48. Faber BW, Remarque EJ, Morgan WD, Kocken CH, Holder AA, et al. (2007) Malaria vaccine-related benefits of a single protein comprising Plasmodium falciparum apical membrane antigen 1 domains I and II fused to a modified form of the 19-kilodalton C-terminal fragment of merozoite surface protein 1. Infection and Immunity 75: 5947-5955.
49. Kennedy MC, Wang J, Zhang YL, Miles AP, Chitsaz F, et al. (2002) In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): Production and activity of an AMA1 vaccine and generation of a multiallelic response. Infection And Immunity 70: 6948.
50. Remarque EJ, Faber BW, Kocken CHM, Thomas AW, (2008) A Diversity-Covering Approach to Immunization with Plasmodium falciparum Apical Membrane Antigen 1 Induces Broader Allelic Recognition and Growth Inhibition Responses in Rabbits. Infect Immun 76: 2660-2670.
51. Cavanagh DR, Dobano C, Elhassan IM, Marsh K, Elhassan A, et al. (2001) Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum. Infection and Immunity 69: 1207-1211.
52. Cavanagh DR, Elhassan IM, Roper C, Robinson VJ, Giha H, et al. (1998) A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. Journal of Immunology 161: 347.
53. Dobano C, Rogerson SJ, Mackinnon MJ, Cavanagh DR, Taylor TE, et al. (2008) Differential antibody responses to Plasmodium falciparum merozoite proteins in Malawian children with severe malaria. J Infect Dis 197: 766-774.
54. Sowa KM, Cavanagh DR, Creasey AM, Raats J, McBride J, et al. (2001) Isolation of a monoclonal antibody from a malaria patient-derived phage display library recognising the Block 2 region of Plasmodium falciparum merozoite surface protein-1. Molecular and Biochemical Parasitology 112: 143-147.
55. Laemmli UK, (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
56. Blum H, Beier H, Gross HJ, (1987) Improved silver staing of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 8: 93-99.
57. McBride JS, Newbold CI, Anand R, (1985) Polymorphism of a high molecular weight schizont antigen of the human malaria parasite Plasmodium falciparum. Journal of Experimental Medicine 161: 160-180.
58. Mahdi Abdel Hamid M, Remarque EJ, van Duivenvoorde LM, van der Werff N, Walraven V, et al. (2011) Vaccination with Plasmodium knowlesi AMA1 Formulated in the Novel Adjuvant Co-Vaccine HT Protects against Blood-Stage Challenge in Rhesus Macaques. PLoS ONE 6: e20547.
59. McBride JS, Newbold CI, Anand R, (1985) Polymorphism of a high molecular weight schizont antigen of the human malaria parasite Plasmodium falciparum. Journal of Experimental Medicine 161: 160.
60. Dodoo D, Theisen M, Kurtzhals JA, Akanmori BD, Koram KA, et al. (2000) Naturally acquired antibodies to the glutamate-rich protein are associated with protection against Plasmodium falciparum malaria. J Infect Dis 181: 1202-1205.
61. Bergmann-Leitner ES, Duncan EH, Mullen GE, Burge JR, Khan F, et al. (2006) Critical evaluation of different methods for measuring the functional activity of antibodies against malaria blood satge antigens. Am J Trop Med Hyg 75: 437-442.
62. Darko CA, Angov E, Collins WE, Bergmann-Leitner ES, Girouard AS, et al. (2005) The Clinical-Grade 42-Kilodalton Fragment of Merozoite Surface Protein 1 of Plasmodium falciparum Strain FVO Expressed in Escherichia coli Protects Aotus nancymai against Challenge with Homologous Erythrocytic-Stage Parasites. Infection And Immunity 73: 287.
63. Arnot DE, Cavanagh DR, Remarque EJ, Creasey AM, Sowa MP, et al. (2008) Comparative testing of six antigen-based malaria vaccine candidates directed toward merozoite-stage Plasmodium falciparum. Clin Vaccine Immunol 15: 1345-1355.
64. Hirel PH, Schmitter MJ, Dessen P, Fayat G, Blanquet S, (1989) Extent of N-terminal methionine excision from Escherichia coli proteins is governed by the side-chain length of the penultimate amino acid. Proceedings of the National Academy of Sciences of the United States of America 86: 8247-8251.